SCHEMBL23414488

SCHEMBL23414488

NO[C@H]1[C@@H](O)[C@H](n2cnc3c(N)ncnc32)O[C@@H]1CO

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 4/20 0.77
▸ ADORA1 P30542 3/20 0.77
▸ SMN1; SMN2 Q16637 2/20 0.77
▸ DPP4 P27487 1/20 0.77
▸ MEN1 O00255 1/20 0.77
▸ SLC28A1 O00337 1/20 0.77
▸ MAP3K7 O43318 1/20 0.77
▸ SLC28A2 O43868 1/20 0.77
▸ GAPDH P04406 1/20 0.77
▸ MAPK1 P28482 1/20 0.77
▸ ADORA2A P29274 1/20 0.77
▸ ADORA2B P29275 1/20 0.77
▸ STAT6 P42226 1/20 0.77
▸ PI4KA P42356 1/20 0.77
▸ KMT2A Q03164 1/20 0.77
▸ PI4K2B Q8TCG2 1/20 0.77
▸ DOT1L Q8TEK3 1/20 0.77
▸ SLC29A1 Q99808 1/20 0.77
▸ PI4K2A Q9BTU6 1/20 0.77
▸ SLC28A3 Q9HAS3 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4658306 1.00 ADORA3 (0.77) ADORA3ADORA1SMN1; SMN2DPP4MEN1
SCHEMBL546471 0.91 ADORA3 (0.77) ADORA3ADORA1SMN1; SMN2DPP4MEN1
SCHEMBL6142045 0.91 ADORA3 (0.77) ADORA3ADORA1SMN1; SMN2DPP4MEN1
SCHEMBL3369124 0.90 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2DPP4MEN1
SCHEMBL21418864 0.90 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2DPP4MEN1
SCHEMBL29748808 0.90 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2DPP4MEN1
SCHEMBL16359953 0.90 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2DPP4MEN1
SCHEMBL15755555 0.90 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2DPP4MEN1
SCHEMBL23547979 0.90 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2DPP4MEN1
SCHEMBL1066939 0.90 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2DPP4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12428658-B2 Methods and compositions for enzymatic polymerization of N3′→P5′ phosphoramidate DNA THE GENERAL HOSPITAL CORPORATION (US) 2025-09-30 — — US claimed
US-20240309418-A1 ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA MASSACHUSETTS GEN HOSPITAL (US) 2024-09-19 — — US claimed
US-20230026693-A1 Methods and Compositions for Enzymatic Polymerization of N3` -> P5` Phosphoramidate DNA THE GENERAL HOSPITAL CORPORATION 2023-01-26 — — US claimed
WO-2021108632-A1 METHODS AND COMPOSITIONS FOR ENZYMATIC POLYMERIZATION OF N3' -> P5' PHOSPHORAMIDATE DNA THE GENERAL HOSPITAL CORPORATION (US) 2021-06-03 — — WO claimed
US-12428658-B2 Methods and compositions for enzymatic polymerization of N3′→P5′ phosphoramidate DNA THE GENERAL HOSPITAL CORPORATION (US) 2025-09-30 — — US disclosed
US-20240309418-A1 ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA MASSACHUSETTS GEN HOSPITAL (US) 2024-09-19 — — US disclosed
US-20230026693-A1 Methods and Compositions for Enzymatic Polymerization of N3` -> P5` Phosphoramidate DNA THE GENERAL HOSPITAL CORPORATION 2023-01-26 — — US disclosed
Send feedback